CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Rising number of industry-academic research collaborations
4.1.2. Increasing research activities and R&D spending by pharmaceutical and biotechnology
companies
4.1.3. Increasing prevalence of HIV/AIDS
4.1.4. Growing demand for personalised medicine
4.2. Market Restraints & Challenges
4.2.1. Stringent regulations and need for high procedural efficiency for accurate results
4.2.2. The emergence of alternative technologies
4.3. Market Opportunities
4.3.1. Emerging economies
4.3.2. Automation in western blotting instruments
CHAPTER 5. GLOBAL WESTERN BLOTTING MARKET – BY PRODUCT
5.1. Consumables
5.1.1. Reagents
5.1.2. Kits
5.1.3. Others
5.3 Instruments
5.2.1. Gel Electrophoresis Instruments
5.2.2. Blotting Systems
5.2.2.1 Wet Blotting Systems
5.2.2.2 Semi-Dry Blotting Systems
5.2.3 Imagers
5.2.3.1. Chemiluminescent Imagers
5.2.3.2. Fluorescent Imagers
5.2.3.3. Others
CHAPTER 6. GLOBAL WESTERN BLOTTING MARKET – BY APPLICATION
6.1. Biochemical & Biomedical Research
6.2. Disease Diagnostics
6.3. Agriculture
6.4. Other
CHAPTER 7. GLOBAL WESTERN BLOTTING MARKET – BY END USER
7.1. Academic and Research Institutes
7.2. Pharmaceutical and Biotechnology Companies
7.3. Diagnostic Laboratories
7.4. Other
CHAPTER 8. GLOBAL WESTERN BLOTTING MARKET - BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.2.4. Costa Rica
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Chile
8.3.4. Columbia
8.3.5. Others
8.4. Europe
8.4.1. U.K.
8.4.2. Germany
8.4.3. France
8.4.4. Italy
8.4.5. Spain
8.4.6. Russia
8.4.7. Netherlands
8.4.8. Switzerland
8.4.9. Poland
8.4.10. Others
8.5. APAC
8.5.1. China
8.5.2. Japan
8.5.3. India
8.5.4. South Korea
8.5.5. Australia & New Zealand
8.5.6. Malaysia
8.5.7. Singapore
8.5.8. Others
8.6. Middle East & Africa
8.6.1. UAE
8.6.2. Saudi Arabia
8.6.3. Iran
8.6.4. Iraq
8.6.5. Qatar
8.6.6. South Africa
8.6.7. Algeria
8.6.8. Morocco
8.6.9. Nigeria
8.6.10. Egypt
8.6.11. Others
CHAPTER 9. GLOBAL WESTERN BLOTTING MARKET - COMPANY PROFILES
9.1. Li-Cor Biosciences
9.2. PerkinElmer, Inc.
9.3. Bio-Techne Corporation
9.4. F. Hoffmann-La Roche Ltd.
9.5. Merck KGaA
9.6. Cell Signaling Technology
9.7. Bio-Rad Laboratories, Inc.
9.8. Thermo Fisher Scientific, Inc.
9.9. GE Healthcare
9.10. Advansta Inc.
9.11. Perkinelmer, Inc.
9.12. Roche Applied Science
9.13. Sigma-Aldrich Corporation
CHAPTER 10. GLOBAL WESTERN BLOTTING MARKET - COMPETITIVE
LANDSCAPE
10.1. Market Share Analysis
10.2. Strategies adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 11. MARKET INSIGHTS
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
CHAPTER 12. APPENDIX
12.1. List of Tables
12.2. List of Figures
